Cizzle Biotechnology Holdings Shares Outstanding History (CIZ)
Cizzle Biotechnology Holdings reported 396.4M shares outstanding at the end of fiscal 2025.
View full Cizzle Biotechnology Holdings company overviewCizzle Biotechnology Holdings annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 396.4M | 0 | 0.00% |
| 2024 | 2024-12-31 | 396.4M | 32.5M | +8.95% |
| 2023 | 2023-12-31 | 363.8M | 24.0M | +7.07% |
| 2022 | 2022-12-31 | 339.8M | — | — |
Cizzle Biotechnology Holdings quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 396.4M | 0 | 0.00% |
| Q4 2024 | 2024-12-31 | 396.4M | — | — |
Cizzle Biotechnology Holdings shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Cizzle Biotechnology Holdings's shares outstanding moved from 339.8M to 396.4M, a change of 56.6M. The latest reported quarter, Q4 2025, shows 396.4M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
reported period-end shares
TickerStat displays period-end common shares from official filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cizzle Biotechnology Holdings source filings ↗